Counterpath Corp
CPAH
CPAH was delisted on the 26th of February, 2021.
10 hedge funds and large institutions have $1.1M invested in Counterpath Corp in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
43% more funds holding
Funds holding: 7 → 10 (+3)
43% more capital invested
Capital invested by funds: $773K → $1.1M (+$329K)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$75.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$26.8K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$502 |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$258 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.36K |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
-$386 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $907K | – | – | – |
|
|
2
Morgan Stanley
New York
| $95K | +$75.7K | +29,412 | +58,824% |
|
|
3
Citadel Advisors
Miami,
Florida
| $33K | +$26.8K | +10,393 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $32K | +$26.2K | +10,166 | New |
|
5
Bank of Montreal
Toronto,
Ontario, Canada
| $28K | – | – | – |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $1K | -$4.36K | -1,691 | -79% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $1K | +$502 | +195 | +3,900% |
|
|
AG
9
Advisor Group
Phoenix,
Arizona
| – | -$386 | -150 | -79% |
|
|
10
CIBC Private Wealth Group
Atlanta,
Georgia
| – | +$258 | +100 | New |
|
CPAH Hedge Fund Activity: Q4 2017 in Review
10 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q4 2017, worth a combined $1.1M — up 43% from $773K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CPAH positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $75.7K. The largest seller was UBS Group, cutting an estimated $4.36K.
- 10 institutional investors held Counterpath Corp (CPAH) as of Q4 2017, up from 7 in Q3 2017.
- Funds reported $1.1M of Counterpath Corp stock for Q4 2017, up 43% quarter-over-quarter.
- 3 funds opened new Counterpath Corp positions in Q4 2017 and 0 closed out, a net change of +3 holders.
- The largest Counterpath Corp buyer in Q4 2017 was Morgan Stanley, an estimated $75.7K added.
- The largest Counterpath Corp seller in Q4 2017 was UBS Group, an estimated $4.36K sold.
Based on aggregated 13F filings for Q4 2017.